UPDATE: GlaxoSmithKline (GSK) Reports Q1 EPS of 25P
GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of GBP0.25. Revenue for the quarter came in at GBP7.4 billion.
Q1 2017 results | |||||
| Q1 2017 |
| Growth | ||
| £m |
| £% |
| CER% |
|
|
|
|
|
|
Turnover | 7,384 |
| 19 |
| 5 |
|
|
|
|
|
|
Total operating profit | 1,718 |
| >100 |
| 100 |
Adjusted operating profit | 1,979 |
| 30 |
| 9 |
 |
|
|
|
|
|
Total earnings per share | 21.4 |
| >100 |
| >100 |
Adjusted earnings per share | 25.0 |
| 31 |
| 9 |
|
|
|
|
|
|
Net cash from operations | 1,144 |
| >100 |
|
|
Free cash flow | 650 |
| >100 |
|
|
|
|
|
|
|
|
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.